Regulation of gene expression in mammalian mitochondria by microRNAs is reported by Zhang et al. During muscle cell differentiation, localization of a miRNA is increased within mitochondria, where it interacts with Ago2 to selectively activate translation of mtDNA-encoded mRNAs. The findings represent a new mitochondrial regulatory pathway and a potentially powerful means to purposefully manipulate mtDNA expression.
Mitochondrial DNA (mtDNA) is essential in mammals, encoding thirteen proteins that are subunits of the ATP-producing oxidative phosphorylation (OXPHOS) complexes. After transcription and processing, mitochondrial mRNAs are translated by a dedicated set of ribosomes (distinct from cytoplasmic ribosomes) utilizing rRNAs and tRNAs that are also encoded by mtDNA (Bestwick and Shadel, 2013) . With the exception of TACO, a translational regulator of the COX1 mRNA (Weraarpachai et al., 2009) , evidence for translational regulation of mitochondrial mRNAs in mammals is sparse. The study by Fu and colleagues in this issue of Cell (Zhang et al., 2014) has broken exciting new ground in this area by showing that microRNAs function in the mitochondrial matrix to upregulate translation of mtDNA-encoded mRNAs (Figure 1) and that this regulation occurs during muscle cell differentiation.
MicroRNAs are short noncoding RNAs that associate with the Argonaute-containing RISC complexes to target specific cytoplasmic mRNAs for degradation or translational repression. In addition to this common form of negative posttranscriptional regulation, microRNAs have been suggested to augment translation under specific circumstances (Vasudevan, 2012) . While the mechanism of this positive regulation is less clear, the lack of a CAP on mRNAs and Argonaute acting independently of its binding partners of the GW182 family have been suggested as critical (Vasudevan, 2012) . A specific characteristic of mitochondrial mRNAs is that they are not capped, thus fulfilling one criterion for positive regulation. In the current study, Zhang et al. show that while Argonaute 2 (Ago2) is in the mitochondrial matrix, none of the GW182 proteins localize to mitochondria (Figure 1 ). Thus, it appears that a unique biological context has arisen to allow upregulation of mitochondrial translation by Ago2 and microRNAs targeting specific mtDNAencoded mRNAs.
Zhang et al. are not the first to show mitochondrial association of microRNAs and to speculate that they exert direct effects in mitochondria (Bandiera et al., 2013) , and there is one report of a microRNA negatively regulating mitochondrial COX1 expression in heart mitochondria (Das et al., 2012) . However, Zhang et al. use a battery of biochemical and cytological assays to clearly demonstrate matrix localization of a specific microRNA, miR-1, and of Ago2, and they provide extensive and compelling evidence that miR-1 binds directly to the mitochondrial ND1 and COX1 mRNAs along with Ago2 to enhance their translation. The authors also find that at least two other mitochondrial-localized microRNAs act similarly.
Since microRNAs are primarily known for their actions on nucleus-encoded mRNAs in the cytoplasm, one question that arises is how microRNAs get into mitochondria in the first place? In fact, it has long been appreciated that RNA molecules are imported into mitochondria. For example, in some organisms the tRNAs for mitochondrial translation are all imported (Tarassov et al., 2007) . In mammals, there are at least two major RNPs (RNase P and RNase MRP) in mitochondria (Shadel and Clayton, 1997 ) that require import of a relatively large RNA subunit into the matrix for assembly and activity. This requires a specific RNA import mechanism and targeting signals in the RNA (Wang et al., 2010) . Whether microRNAs enter mitochondria by this mechanism or another parallel pathway and if this is regulated will be important to decipher.
The entry point for the study by Zhang et al. was their observation that mtDNAencoded proteins were uniquely upregulated in muscle and in differentiating mouse C2C12 cells in a manner that does not involve an increase in mtDNA or mitochondrial transcripts. In the end, they showed that the increase in ND1 and COX1 protein was driven, at least in part, by increased miR-1 in mitochondria targeting these RNAs for enhanced translation in conjunction with Ago2. While the precise requirement for this new form of regulation in muscle differentiation was not ultimately revealed in the study, it begs the question of what role microRNA regulation of mitochondrial translation plays in vivo. While many scenarios can be envisioned, one interesting possibility is that partitioning of the relative amounts of certain microRNAs in the cytoplasm and mitochondria regulates their activity on specific targets to coordinate mitochondrial activities with other cellular functions. In this regard, the observation by Zhang et al. that miR-1 simultaneously represses cytoplasmic targets and activates mitochondrial mRNAs is intriguing (Figure 1) . One potential manifestation of this type of regulation might be to modulate the OXPHOS system to accommodate specific cellular demands. For example, if a microRNA targeted both a nuclear-and mtDNA-encoded subunits of the same OXPHOX complex, increased import into mitochondria and depletion in the cytoplasm might simultaneously increase translation in both compartments. This may be a means to enhance or coordinate complex assembly by controlling the relative expression of nuclear and mtDNA-encoded subunits to remodel the amount or activity of specific OXPHOS complexes. During processes like cell growth and differentiation (e.g., muscle differentiation) that have unique energy requirements or rely on specific mitochondria-generated signals like reactive oxygen species, such control mechanisms may be critical.
The identification of a functional microRNA pathway in mitochondria poses important questions for how mitochondrial gene expression is controlled in vivo, adding a new form of positive translational regulation to the list of possibilities. The findings also open the door to asking important basic questions about how assembly of the OXPHOS system is controlled by providing an experimental means to perturb mtDNA expression in specific ways in cell models and perhaps in mice (e.g., through microRNA mimics that would specifically target one mtDNA-encoded subunit).
Finally, many mitochondrial diseases are caused by defects in mitochondrial translation (Pearce et al., 2013) . Thus, the ability to upregulate mitochondrial translation using a microRNA-based strategy may be a new therapeutic route for these severe diseases which currently have no cure and few treatment options. A subset of microRNAs (e.g., miR-1 and others in the Zhang et al. study) is located both in the cytoplasm and the mitochondrial matrix where they bind separate targets and mediate different outcomes. In the cytoplasm, microRNAs bind their mRNA targets along with RISC complexes containing Ago2 (pink oval) and a GW182 family protein (yellow oval) to repress translation. MicroRNAs that enter mitochondria, by a yet-to-be defined import system (peach), associate with mtDNA-encoded mRNAs along with Ago2 that is presumably imported through the normal protein import complexes (purple). Because GW182 family proteins are not imported into mitochondria (red X) and mtDNA-encoded mRNAs are not capped (circle on the cytoplasmic mRNA denotes a CAP), the mitochondrial Ago2-microRNA complexes stimulate, rather than repress, translation. This form of regulation likely leads to unique alterations in OXPHOS complex assembly and activity to tailor mitochondrial function to specific cell types and physiological cues.
